基于网络药理学的宫外孕Ⅰ号方治疗异位妊娠的作用机制研究

Abstract
Figure/Table
References (39)
Related Citation (15)

Download: PDF (1831 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To study the effect of ectopic pregnancy Ⅰ prescription on the treatment target of ectopic pregnancy by network pharmacology. Methods Based on the traditional Chinese medicine systems pharmacology database and analysis platform, as well as the known effective active ingredients of ectopic pregnancy Ⅰ prescription in relevant literatures from January 2015 to January 2020 on CNKI, VIP and Wanfang websites, the active ingredients of the prescription were finally screened out. After obtaining all the traditional Chinese medicine ingredients, oral bioavailability and drug-likeness were taken as the screening conditions to obtain the effective gene targets of the above active ingredients through the Uniprot website. Finally, an “active ingredient-target” network was established with the help of Cytoscape 3.8.0. Disgenet database and GeneCards database were used to retrieve disease targets of ectopic pregnancy. The ectopic pregnancy Ⅰ prescription was intersected with the disease target. Proteinprotein interaction (PPI) networks were constructed and mapped using the Bisogenet plugin in Cytoscape 3.8.0 software. Top three degree value of the target proteins and effective components of the drug in the RSCB PDB database, Autodock Tolls software and Pymol software were used to make molecular docking operation. At the same time, the DAVID database was used for GO classification enrichment analysis and KEGG pathway enrichment analysis of key targets in PPI network diagram. Results A total of 159 effective targets for ectopic pregnancy Ⅰ prescription and 1362 disease targets for ectopic pregnancy were screened out. After the intersection of the two, 65 targets for ectopic pregnancy treatment were obtained. Based on molecular docking of the top 3 proteins and active components in the PPI network with degree values, it was concluded that the core component of ectopic pregnancy Ⅰ prescription had good binding activity with the target of ectopic pregnancy. GO enrichment analysis results showed that among the 220 related target genes, 207 core target genes were involved in enrichment, and a total of 518 enrichment results were obtained, including 174 molecular functions, 126 cell components, and 218 biological processes. KEGG analysis showed that there were 220 related target genes, among which 181 core target genes were involved in 111 signaling pathways. Molecular docking and enrichment analysis showed that ectopic pregnancy Ⅰ prescription was effective in the treatment of ectopic pregnancy mainly by acting on NTRK1 and other proteins through signaling pathways such as tumor signaling pathway. Conclusion The ectopic pregnancy Ⅰ prescription can act on multiple targets of ectopic pregnancy and participate in the regulation of multiple signaling pathways, which can provide a new direction for the study of its pharmacological mechanism.

Key words： Ectopic pregnancy Ⅰ prescription Ectopic pregnancy Network pharmacology Mechanism

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	QIU Jiahan1 YUAN Shuo1 ZHANG Jiaqi2 KUANG Zijun2

Cite this article:

QIU Jiahan1 YUAN Shuo1 ZHANG Jiaqi2 KUANG Zijun2. Study on the mechanism of treatment of ectopic pregnancy Ⅰ prescription based on network pharmacology[J]. 中国医药导报, 2021, 18(22): 4-11.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2021/V18/I22/4

[1] 孙会静，代艳，韦彤彤.大剂量甲氨蝶呤治疗儿童急性淋巴细胞白血病不良反应的临床分析[J].中国医院药学杂志，2020（4）：423-426.
[2] 林峰，王春燕，汤丽娜，等.大剂量甲氨蝶呤治疗骨肉瘤导致肝功能损伤的危险因素分析[J].肿瘤，2014，34（5）：450-453.
[3] 戚丽，刘春华，张君燕.三阶段法治疗包块型异位妊娠[J].实用医药杂志，2006，23（3）：308-309.
[4] 药朝昕，于载畿.中西医结合治疗宫外孕的现状与展望[J].中西医结合杂志，1984（4）：249-251.
[5] 于载畿.中西医结合治疗宫外孕[J].实用妇科与产科杂志，1986（3）：123-124.
[6] 单鸿仁，王竹梅，王惠云.宫外孕方剂对家兔血浆肝素耐量试验及凝血时间影响的研究[J].新医学，1980（3）：139-140.
[7] 邱嫔，廖慧妍，李安，等.化瘀消癥颗粒治疗早期输卵管妊娠的临床疗效观察[J].广州中医药大学学报，2019，36（2）：209-214.
[8] 袁烁，邓高丕，林夏静.加味宫外孕Ⅰ号方对体外培养的输卵管妊娠滋养细胞凋亡相关基因影响的研究[J].时珍国医国药，2014，25（2）：270-271.
[9] 袁烁，刘玲，邓高丕.加味宫外孕Ⅰ号方含药血清对体外培养的输卵管妊娠滋养细胞凋亡率和细胞周期的影响[J].中华中医药学刊，2015，33（11）：2598-2600.
[10] 孙建华，郜洁，刘开飞，等.化瘀消癥颗粒对人绒毛膜滋养层细胞HTR-8/SVneo侵袭迁移的影响[J].中成药，2019，41（11）：2761-2765.
[11] 王焱皙，朱芳芳，张莹轩，等.基于自噬稳态调控的化瘀消癥颗粒治疗输卵管妊娠机制研究[J].中华中医药杂志，2020，35（5）：2379-2383.
[12] Ru J，Li P，Wang J，et al. TCMSP：a database of systems pharmacology for drug discovery from herbal medicines [J]. J Cheminform，2014，6：13.
[13] Li J，Zhao P，Li Y，et al. Systems pharmacology-based dissection of mechanisms of Chinese medicinal formula Bufei Yishen as an effective treatment for chronic obstructive pulmonary disease [J]. Sci Rep，2015，5，15290.
[14] Stelzer G，Rosen N，Plaschkes I，et al. The GeneCards Suite：From Gene Data Mining to Disease Genome Sequence Analysis [J]. Curr Protoc Bioinformatics，2016， 54：1.30.1-1.30.33. doi：10.1002/cpbi.5.
[15] Pi?觡ero J，Ramírez-Anguita JM，Saüch-Pitarch J，et al. The DisGeNET knowledge platform for disease genomics：2019 update [J]. Nucleic Acids Res，2020，48（D1）：D845-D855. doi：10.1093/nar/gkz1021.
[16] Huang da W，Sherman BT，Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID [J]. Nat Protoc，2009，4（1）：44-57.
[17] 曹泽毅.中华妇产科学[M].北京：人民卫生出版社，2008：191-193.
[18] 袁烁，陈敏红，卢如玲，等.基于细胞周期与细胞侵袭力探讨化瘀消癥复方对输卵管妊娠滋养细胞影响[J].时珍国医国药，2019，30（1）：48-52.
[19] 吴齐斌，宋一一，祝建芳，等.Nanog和p53蛋白在妊娠滋养细胞疾病中的表达及临床意义[J].中国妇产科临床杂志，2020，21（2）：179-183.
[20] 陈欣，郭端英，付振琳，等.miR-520激活内质网应激导致滋养细胞凋亡的相关研究[J].生殖医学杂志，2020， 29（8）：1067-1073.
[21] 彭海燕，李华萍.miR-137过表达滋养细胞对血管内皮细胞生物学功能的调节作用[J].上海交通大学学报：医学版，2017，37（10）：1350-1356.
[22] 梁卫桃.PI3K/AKT信号通路在IGF-1调控滋养层细胞分泌β-hCG和孕酮中的作用研究[D].兰州：兰州大学，2020.
[23] 李志芳.STOX1通过PI3K/AKT信号通路对滋养细胞功能的调控及在早期不明原因复发性流产中作用机制研究[D].合肥：安徽医科大学，2019.
[24] 张展，黄晨曦，王萍，等.LncRNA WDR86-AS1调节FOXO3a对滋养细胞增殖和侵袭能力的影响[J].暨南大学学报：自然科学与医学版，2020，41（3）：197-203.
[25] 张孝丽，车立群，吴红敬，等.FOXO3a通过PI3K/AKT信号通路介导炎症因子TNF-α抑制滋养细胞的增殖、侵袭及促进细胞发生凋亡[J].免疫学杂志，2020，36（6）：482-489.
[26] Sun Y，Liu WZ，Liu T，et al. Signaling pathway of MAPK/ERK in cell proliferation，differentiation，migration，senescence and apoptosis [J]. J Recept Signal Transduct Res，2015，35（6）：600-604.
[27] 马铭艳，杨美霞，韩晓敏，等.MAPK信号通路在自然流产中机制研究进展[J].中国计划生育学杂志，2020，28（9）：1504-1508.
[28] 白冰，李娟，罗欣，等.滋养细胞侵袭力分子调节机制的研究进展[J].重庆医科大学学报，2013，38（10）：1110-1113.
[29] Kn?觟fler M. Critical growth factors and signalling pathways con－trolling human trophoblast invasion [J]. Int J Dev Biol，2010，54 （2/3）：269-280.
[30] 慕华桥，漆洪波，刘西茹.SB203580对氧化应激下人绒毛外滋养细胞生物学功能的影响[J].上海交通大学学报：医学版，2017，37（2）：172-176.
[31] Hanahan D，Weinberg RA. The Hallmarks of Cancer [J]. Cell，2000，100（1）：57-70.
[32] Hanahan D，Weinberg RA. Hallmarks of Cancer：The Next Generation [J]. Cell，2011，144（5）：646-674.
[33] 何宜静，欧琼，李婷，等.过表达NDRG1通过调控VEGF/sFlt-1轴增强缺氧条件下滋养细胞的促血管形成能力[J].安徽医科大学学报，2020，55（5）：745-750.
[34] 项生群，董金华，毛书辉.SATB1调节滋养细胞EMT信号通路在子痫前期发生中作用及其临床价值探讨[J].中国现代医生，2019，57（6）：33-36.
[35] 于子婕，卢实.环孢素A治疗反复性自然流产的研究进展[J].华中科技大学学报：医学版，2020，49（3）：375-377.
[36] 姚寒梅，邓高丕.不同方法提取化瘀消癥复方对HTR-8/SVneo细胞凋亡的影响[J].中华中医药学刊，2016，34（12）：2827-2830.
[37] 袁烁，刘玲，王瑞雪，等.输卵管妊娠绒毛滋养层细胞的体外培养与鉴定[J].中国妇幼保健，2016，31（3）：550-553.
[38] 简咏男,郑文兰.输卵管妊娠滋养细胞的体外培养与鉴定[J].中国医药导报，2020，17（19）：8-10，15，198.
[39] 袁烁，邓高丕.化瘀消癥杀胚复方含药血清对体外培养输卵管妊娠滋养细胞凋亡的影响[J].中华中医药杂志，2012，27（4）：1003-1007.